United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News Cytokinetics bags FDA breakthrough therapy status for aficamten in oHCM Cytokinetics has secured breakthrough therapy designation from the US Food and Drug Administration (FDA) for aficamten for the… bySrinathDecember 11, 2021